RETA - The 2 Nasdaq Biotech Stocks to Watch Thursday
After three days of strong gains, Wall Street looks ready to take a bit of a break. Thursday morning brought modest pullbacks in most major stock indexes, as market participants turn their attention to economic data over the next couple of days to guide their longer-term strategies. As of 8:15 a.m. ET, futures on the Nasdaq Composite (NASDAQINDEX: ^IXIC) were down 54 points to 16,338, giving back just a small portion of the index's advance since early Monday.
Biotech stocks have been a key driver of the Nasdaq's advance over the past year and a half. These stocks are notoriously volatile, because news can lead to big gains or gut-wrenching disappointment. Investors are seeing a bit of both Thursday morning, as Aurinia Pharmaceuticals (NASDAQ: AUPH) and Reata Pharmaceuticals (NASDAQ: RETA) just released information that sent their shares moving. Below, we'll talk about both biotechs and which one is moving higher.
Image source: Getty Images.
For further details see:
The 2 Nasdaq Biotech Stocks to Watch Thursday